Objective: Evaluate the economic burden of cystic fibrosis treatment in Palestine and demonstrate the cost-benefit of introducing new therapeutic options. A willingness to pay survey to assess the patients’/families’ ability to contribute to the cost of these new medications was used. Method: A crosssectional study of CF patients attending pediatric pulmonology clinic at Caritas Baby Hospital (CBH) between January and May, 2017